Narrative Update • Jun 26
Have your own idea? Try our Stock Screener
German (DAX) Biotech Industry Analysis
UpdatedAug 01, 2026
DataAggregated Company Financials
Companies13
- 7D0.4%
- 3M-4.7%
- 1Y8.2%
- YTD6.1%
In the last week, the Biotech industry is flat overall, with Heidelberg Pharma standing out by going down 5.3%. The past year has been better, since the industry has gained 8.2% in that time. Earnings are forecast to grow by 82% annually.
Industry Valuation and Performance
Has the German Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Sat, 01 Aug 2026 | €3.6b | €765.3m | -€165,087,270.61 | 80.1x | -21.8x | 4.7x |
| Mon, 29 Jun 2026 | €3.6b | €761.1m | -€173,540,836.94 | 94.1x | -20.8x | 4.8x |
| Wed, 27 May 2026 | €3.7b | €739.6m | -€135,373,927.59 | 69.4x | -27.6x | 5x |
| Fri, 24 Apr 2026 | €3.8b | €714.4m | -€219,585,497.04 | 9.6x | -17.2x | 5.3x |
| Sun, 22 Mar 2026 | €3.6b | €744.0m | -€183,702,831.44 | 4.2x | -19.7x | 4.9x |
| Tue, 17 Feb 2026 | €3.4b | €744.1m | -€183,573,872.32 | 5x | -18.6x | 4.6x |
| Thu, 15 Jan 2026 | €3.5b | €744.0m | -€183,371,938.86 | 3.9x | -18.9x | 4.7x |
| Sat, 13 Dec 2025 | €3.4b | €744.2m | -€190,935,109.26 | 3.4x | -17.6x | 4.5x |
| Mon, 10 Nov 2025 | €3.0b | €755.4m | -€211,322,236.64 | 3.5x | -14.2x | 4x |
| Wed, 08 Oct 2025 | €3.4b | €756.5m | -€208,584,017.83 | 3.5x | -16.1x | 4.4x |
| Fri, 05 Sep 2025 | €2.1b | €121.3m | -€204,057,579.57 | 3.5x | -10.3x | 17.3x |
| Sun, 03 Aug 2025 | €3.5b | €772.4m | -€188,693,021.02 | 4x | -18.3x | 4.5x |
| Tue, 01 Jul 2025 | €2.3b | €772.7m | -€178,999,093.00 | 4.1x | -12.9x | 3x |
| Thu, 29 May 2025 | €2.2b | €772.7m | -€178,999,093.00 | 3.9x | -12.3x | 2.8x |
| Sat, 26 Apr 2025 | €2.2b | €836.7m | -€141,762,276.00 | 24.3x | -15.4x | 2.6x |
| Mon, 24 Mar 2025 | €2.2b | €795.3m | €73.6m | 14.1x | 30.3x | 2.8x |
| Wed, 19 Feb 2025 | €2.4b | €791.8m | €74.2m | 13.6x | 31.9x | 3x |
| Fri, 17 Jan 2025 | €2.8b | €791.8m | €74.2m | 15.8x | 37.2x | 3.5x |
| Sun, 15 Dec 2024 | €2.6b | €791.8m | €74.2m | 14.6x | 35.6x | 3.3x |
| Tue, 12 Nov 2024 | €2.6b | €866.1m | €170.1m | 11.9x | 15.1x | 3x |
| Thu, 10 Oct 2024 | €2.7b | €867.2m | €175.9m | 11.9x | 15.6x | 3.2x |
| Sat, 07 Sep 2024 | €2.6b | €867.2m | €174.8m | 12x | 14.8x | 3x |
| Mon, 05 Aug 2024 | €2.6b | €885.2m | €194.8m | 11.3x | 13.2x | 2.9x |
| Wed, 03 Jul 2024 | €2.7b | €884.7m | €210.9m | 12.8x | 12.8x | 3x |
| Fri, 31 May 2024 | €2.5b | €884.7m | €188.0m | 10x | 13.5x | 2.9x |
| Sun, 28 Apr 2024 | €2.5b | €780.6m | €151.1m | 9.1x | 16.8x | 3.2x |
| Tue, 26 Mar 2024 | €5.1b | €985.3m | -€230,465,249.80 | 11.8x | -22.2x | 5.2x |
| Thu, 22 Feb 2024 | €2.7b | €746.1m | -€35,822,108.00 | 12.3x | -76.5x | 3.7x |
| Sat, 20 Jan 2024 | €2.7b | €769.9m | -€145,885,802.00 | 12.9x | -18.8x | 3.6x |
| Mon, 18 Dec 2023 | €2.8b | €779.7m | -€160,010,802.00 | 13.5x | -17.7x | 3.6x |
| Wed, 15 Nov 2023 | €3.9b | €1.1b | -€71,826,014.00 | 12.2x | -54.3x | 3.6x |
| Fri, 13 Oct 2023 | €3.7b | €962.8m | -€172,995,145.00 | 9x | -21.4x | 3.8x |
| Sun, 10 Sep 2023 | €4.0b | €971.6m | -€197,588,171.00 | 11.3x | -20x | 4.1x |
| Tue, 08 Aug 2023 | €4.1b | €955.5m | -€219,213,323.00 | 30x | -18.8x | 4.3x |
Price to Earnings Ratio
-18.8x
Current Industry PE
- Investors are optimistic on the German Biotechs industry, and appear confident in long term growth rates.
- The 3-year average PS ratio of 4.1x is lower than the industry's current PS ratio of 4.7x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Meanwhile revenues for these companies have declined 7.1% per year.
- This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.
Industry Trends
Which industries have driven the changes within the German Healthcare industry?
| DE Market | 1.75% | |
| Healthcare | 3.21% | |
| Biotech | 0.42% | |
| Biotech | 0.42% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| FYB Formycon | €19.18 | 1.6% +€5.3m | -27.5% | PS6.5x | |
| 7ZT Hamlet BioPharma | €0.65 | 2.0% +€2.4m | 37.3% | PS25226.3x | |
| LQ0 Dextech Medical | €0.89 | 3.0% +€480.6k | 42.7% | PS43.6x | |
| 20B Biomark Diagnostics | €0.32 | 1.3% +€425.9k | 73.3% | PS933.1x | |
| 8V8 Genetic Analysis | €0.045 | 3.7% +€110.5k | -13.4% | PS1.6x |